简介:BackgroundHeartfailureisoneofthemaincausesofdeathduetoprogressivemusculardystrophyofDuchennemusculardystrophy(DMD)inthemajorityofthecases.ThereishighincidenceofarterialthromboembolisminDMDpatientswithsevereheartfailure.However,ithasbeenreceivinglittleattentionwhetheranticoagulativetherapyinDMDpatientswithsevereheartfailureinsinusrhythmshouldbeperformed.HereinwepresentacaseofDMDpatients,withsevereheartfailureinsinusrhythm,whopresentsalargemuralthrombusformationatleftventricularanteriorwall.
简介:BackgroundTheremaybedysregulationofcirculatingmicroRNAsinacutemyocardialinfarction(AMI),whichisanaging-relatedprocess.However,thedifferencebetweenyoungandelderlypeopleinexpressionlevelofcirculatingmiR-21inAMIpatientshasnotbeeninvestigated.MethodsThestudyincluded72consecutivepatientswithAMI.ThegroupIconsistedof43patientsagedequaltoorabove65yearsandthegroupIIconsistedof29patientsagedequaltoorbelow45years.Real-timeRT-PCRwasappliedtodetectserummiR-21expressionlevelsatthetimeofmechanicalreperfusionand12h,D1,D3andD7afterPCI,respectively.ResultsTheexpressionlevelofmiR-21inAMIpatientsincreasedmarkedly12hafterPCIandreachedthepeakatD1afterPCIinbothgroups.TherewasnodifferenceofmiR-21expressionbetweenGroupⅠandⅡatthetimeofmechanicalreperfusion(5.12±0.73vs.4.98±0.87)andD7afterPCI(1.28±0.75vs.1.94±0.89),However,groupⅠpatientsexhibitedhighermiR-21expressionlevelthangroupⅡat12h(7.96±0.78vs.4.23±0.77,P<0.05),D1(9.32±0.89vs.6.12±0.92,P<0.05)andD3(4.78±0.91vs.2.97±0.77,P<0.05)afterPCI,respectively.ConclusionOurdatarevealanincreaseofmiR-21inpatientswithAMImaybeamechanismofmyocardialischemiareperfusioninjury.TheexpressionofmiR-21wasrelatedtothedevelopmentandprogressionofAMI,andthereisanage-relatedchangeintheexpressionofmiR-21inacutemyocardialinfarctionpatients.
简介:ObjectivesToassessfive-yearresultsaftersuccessfulpercutaneousmechanicalmitralcommissurotomy(PMMC).MethodsThirty-fourselectedpatientswithrheumaticmitralstenosisunderwentPMMCsuccessfullyinGuangdongcardiovascularinstitutebetweenFebruary2001andAugust2002.Serialechocardiogramswereperformedinallpatientsatbaseline,dischargeandannuallythereafter.ResultsFive-yearfollow-upratewas97.1%.Five-yearsurvivalratewas100%.BeforeandafterPMMCandatfollow-up,meanmitralvalveareabytwo-dimensionalechocardiographywas(0.87±0.15)cm2,(2.11±0.38)cm2and(1.81±0.36)cm2,respectively(P<0.01).Five-yearmitralrestenosisratewas6.1%.ConclusionPMMCcanachieveexcellentandsustainedlong-termresultsinselectedpatientswithmitralechocardiographicscoreexceedingorbeingequalto9.
简介:BackgroundInpatientswithacutecoronarysyndrome(ACS),loweradmissionsystolicbloodpressure(SBP)levelsinferaworseprognosis.However,thepredictivepotentialofadmissionSBPon1-yearmortalityhasnotfullyelucidatedinpatientswithnon-ST-segmentelevationACS(NSTEACS).MethodsWeenrolled1325patientstoinvestigatetheassociationbetweenadmissionSBPinpatientshospitalizedforNSTEACS.WeanalyzedtheassociationbetweenadmissionSBPand1-yearmortality.AdmissionSBPwascategorizedaslow(<110mmHg),normal(110-140mmHg),high(141-160mmHg),andveryhigh(>160mmHg).ResultsComparedwithpatientswithnormaladmissionSBP,thosewithlowSBPhadasignificantlyincreasedhazardratios(HRs)for1-yearmortalityof3.03(P<0.05),whilepatientswithhighandveryhighadmissionSBPhadnosignificantlyincreasedHRsfor1-yearmortality.ConclusionLowadmissionSBP,butnotelevatedadmissionSBP,isastrongindependentpredictorof1-yearmortalityinpatientswithNSTEACS.